A call between the Gates Foundation and Likarda, a Kansas City-based biotech company, led to the company winning a grant for development of a new HIV therapy.Gates Foundation taps Kansas City biotech Likarda for HIV treatment research
A call between the Gates Foundation and Likarda, a Kansas City-based biotech company, led to the company winning a grant for development of a new HIV therapy.